EP1736484A4

An gene engineering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 29 March 2025, 1.5 years ago.

Parties

Owner: DONGGUANG HAOFA BIOTECHNOLOGY
Assigned now: BEIJING ABT GENETIC ENGINEERIN
BEIJING ABT GENETIC ENGINEERING TECHNOLOGY CO LTD
DONGGUANG HAOFA BIOTECHNOLOGY DEVELOPMENTAL CO LTD
Applicants: Beijing ABT Genetic Engineering Technology Co., Ltd.
Dongguang Haofa Biotechnology Developmental Co. Ltd
Inventors: WANG, Xiangbin, Beijing 102206, China
HUANG, Hualiang, Beijing 102206, China
ZHAO, Baofeng, Beijing 102206, China
ZHAO, Qi, Beijing 102206, China
and 2 more inventorsShow fewer
PIAO, Jinhua, Beijing 102206, China
LIN, Qing, Beijing 102206, China

Examination

Examiner: Vadot, Pierre
Agent: Viering, Hans-Martin

Reach

Cites: 2 non-patent works⁠
Family: 17 members in 10 offices⁠EP3AT2CA2CN2JP2RU2DEES+2

Classification

CPC: C07K16/00A61K2039/505C07K16/2809C07K16/2818C07K16/3007C07K2317/626+4 more
IPC: C07K16 18A61K39 395A61P35 00C07K16 28C07K16 30C07K19 00+4 more

Every citation, both ways

Citations
Reference	Relation	Cited during
SONG LI-PING ET AL: "A NEW MODEL OF TRISPECIFIC ANTIBODY WITH CYTOTOXICITY AGAINST TUMOR CELLS", SHENGWU HUAXUE YU SHENGWU WULI XUEBAO - ACTA BIOCHIMICA ET BIOPHYSICA SINICA, SHANGHAI KEXUE JISHU CHUBANSHE, SHANGHAI,, CN, vol. 35, no. 6, June 2003 (2003-06-01), pages 503 - 510, XP002388106, ISSN: 0582-9879	Non-patent	Search report
HOLLIGER P ET AL: "Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induces by anti-CD3anti CEA bispecific diabodies and B7antiCEA bispecific fusion proteins", CANCER RESEARCH, vol. 59, 1999, pages 2909 - 2916, XP002477702	Non-patent	Search report

17 members in 10 offices; this record represents the family

This recordMember, by publication datePriority claim

Priority claims3

Priority claims
Document	Office	Kind	Date
200410032158	China	–	2004-04-01
200410032158	China	A	2004-04-01
2005000408	China	W	2005-03-29

Members17

Family members, oldest first
Document	Office	Kind
CN1563092A	China	A	2005-01-12
CA2561826A1	Canada	A1	2005-10-13
WO2005095456A1	World Intellectual Property Organization (WIPO)	A1	2005-10-13
EP1736484A1	European Patent Office (EPO)	A1	2006-12-27
JP2007535915A	Japan	A	2007-12-13
CN100376599C	China	C	2008-03-26
RU2006138490A	Russian Federation	A	2008-05-20
EP1736484A4This record	European Patent Office (EPO)	A4	2008-06-11
US2009117108A1	United States of America	A1	2009-05-07
RU2361878C2	Russian Federation	C2	2009-07-20
EP1736484B1	European Patent Office (EPO)	B1	2010-10-06
AT483731T	Austria	T	2010-10-15
ATE483731T1	Austria	T1	2010-10-15
DE602005023968D1	Germany	D1	2010-11-18
ES2351510T3	Spain	T3	2011-02-07
JP4648382B2	Japan	B2	2011-03-09
CA2561826C	Canada	C	2012-06-05

70 legal events, as 9 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2015-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-07-01	Announcement of lapse in spainLapsedFD2A	FD2A	ES
2015-03-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-15	Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119	R119	DE
2014-12-26	Notification of lapseLapsedST	ST	FR
2014-11-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-11-26	Gb: european patent ceased through non-payment of renewal feeCeasedGBPC	GBPC	EP
2014-11-04	Ep patent has lapsedLapsedEUG	EUG	SE
2014-10-31	Patent ceasedCeasedPL	PL	CH
2014-10-01	Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119	R119	DE
2013-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2013-09-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2013-08-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2013-08-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2013-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2013-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2013-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2013-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2013-06-28	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2013-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2013-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2012-01-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2012-01-04	Patent lapsedLapsedMM4A	MM4A	IE
2011-11-03	No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097	R097	DE
2011-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-09-14	No opposition filedOpposition26N	26N	EP
2011-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-08-12	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
2011-08-12	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
2011-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-04-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-03-25	Lt: invalidation of european patent or patent extensionLTIE	LTIE	EP
2011-02-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-02-09	Discontinued in the netherlands as no translation has been filedVDEP	VDEP	NL
2011-02-07	Definitive protectionFG2A	FG2A	ES
2011-01-18	Translation of granted ep patentGrantedTRGR	TRGR	SE
2010-11-18	Corresponds to:REF	REF	EP
2010-11-10	European patents granted designating irelandGrantedFG4D	FG4D	IE
2010-10-29	New agentNV	NV	CH
2010-10-15	European patent takes effect as a national patent in ch/liEP	EP	CH
2010-10-06	Designated contracting statesAK	AK	EP
2010-10-06	European patent grantedGrantedFG4D	FG4D	GB
2010-09-03	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
2010-08-27	Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS	GRAS	EP
2010-04-21	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2010-04-13	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP	GRAP	EP
2009-07-08	First examination report despatched17Q	17Q	EP
2008-06-11	Supplementary search report drawn up and despatchedA4	A4	EP
2007-07-11	Request for extension of the european patent (deleted)DAX	DAX	EP
2007-01-31	Title (correction)AN GENE ENGINEERING RECOMBINANT ANTI-CEA, ANTI-CD3 AND ANTI-CD28 SINGLE-CHAIN TRI-SPECIFIC ANTIBODYRTI1	RTI1	EP
2006-12-27	Request for examination filed17P	17P	EP
2006-12-27	Designated contracting statesAK	AK	EP
2006-11-24	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP